Shennon Biotechnologies

Shennon Bio is a biotech company that uses a proprietary ultra‑high‑throughput single‑cell platform to functionally profile and manipulate millions of immune cells for target discovery. By identifying rare, hard‑to‑find cellular targets, the company develops more precise immunotherapies and is initially advancing T‑cell engagers for solid tumors and autoimmune diseases. Shennon pairs this technology with an interdisciplinary, people‑centered culture focused on collaboration, ownership, and translating cellular insights into next‑generation treatments.